To investigate the early neurodegenerative changes of inner retina and choroid in type 1 and type 2 diabetic patients without retinopathy and with early-stage retinopathy.
Methods
In this observational cross-sectional study, 90 right eyes of 90 naive type 1 and 2 diabetic patients without diabetic retinopathy (DR) and with mild to moderate nonproliferative DR (NPDR) were analyzed. Forty healthy eyes were included as controls. We used spectral-domain optical coherence tomography to evaluate the ganglion cell complex (GCC) thickness, the retinal nerve fiber layer (RNFL) thickness, the choroid thickness, and the central foveal thickness (CFT) of patients and controls.
Results
Average GCC thickness turned out to be thinner in type 2 diabetic patients with no DR and with NPDR compared to controls (p = 0.046 and p = 0.041, respectively). The RNFL thickness and CFT were similar among the studied groups and compared to controls (p = 0.78 and p = 0.104, respectively). Average choroid thicknesses (both in the subfoveal area and in a 1-mm radius circular area) were significantly thinner in type 2 diabetic patients with no DR and NPDR, compared to DMT1 groups and controls (both p<0.0001). The GCC and choroid thickness changes were not correlated in any of the investigational groups.
Conclusions
Type 2 diabetic patients without retinopathy and with early-stage retinopathy have inferior thickness values of GCC and choroid compared to controls. Insulin resistance might be a possible adjunctive pathogenetic aspect of neurodegeneration.
MizutaniMKernTSLorenziMAccelerated death of retinal microvascular cells in human and experimental diabetic retinopathy.J Clin Invest199697(12)2883–2890
2.
OlaMSNawazMISiddiqueiMMAl-AmroSAbu El-AsrarAMRecent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy.J Diabetes Complications201226(1)56–64
3.
BarberAJLiethEKhinSAAntonettiDABuchananAGGardnerTWNeural apoptosis in the retina during experimental and human diabetes.Early onset and effect of insulin. J Clin Invest1998102(4)783–791
4.
Abu-El-AsrarAMDralandsLMissottenLAl-JadaanIAGeboesKExpression of apoptosis markers in the retinas of human subjects with diabetes.Invest Ophthalmol Vis Sci200445(8)2760–2766
5.
SimóRHernándezCEuropean Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR).Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives. Trends Endocrinol Metab201425(1)23–33
6.
KimMKimSSKwonHJKohHJLeeSCAssociation between choroidal thickness and ocular perfusion pressure in young, healthy subjects: enhanced depth imaging optical coherence tomography study.Invest Ophthalmol Vis Sci201253(12)7710–7717
7.
GohS-YCooperMEClinical review: The role of advanced glycation end products in progression and complications of diabetes.J Clin Endocrinol Metab200893(4)1143–1152
8.
ZongHWardMStittAWAGEs, RAGE, and diabetic retinopathy.Curr Diab Rep201111(4)244–252
9.
LorenziMThe polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient.Exp Diabetes Res2007200761038
10.
GeraldesPKingGLActivation of protein kinase C isoforms and its impact on diabetic complications.Circ Res2010106(8)1319–1331
11.
HernándezCDal MonteMSimóRCasiniGNeuroprotection as a Therapeutic Target for Diabetic Retinopathy.J Diabetes Res201620169508541
12.
FryczkowskiAWSatoSEHodesBLChanges in the diabetic choroidal vasculature: scanning electron microscopy findings.Ann Ophthalmol198820(8)299–305
13.
BranchiniLRegatieriCVFlores-MorenoIBaumannBFujimotoJGDukerJSReproducibility of choroidal thickness measurements across three spectral domain optical coherence tomography systems.Ophthalmology2012119(1)119–123
14.
RegatieriCVBranchiniLCarmodyJFujimotoJGDukerJSChoroidal thickness in patients with diabetic retinopathy analyzed by spectral-domain optical coherence tomography.Retina201232(3)563–568
15.
QuerquesGLattanzioRQuerquesLet al.Enhanced depth imaging optical coherence tomography in type 2 diabetes.Invest Ophthalmol Vis Sci201253(10)6017–6024
16.
LeeHKLimJWShinMCComparison of choroidal thickness in patients with diabetes by spectral-domain optical coherence tomography.Korean J Ophthalmol201327(6)433–439
17.
EsmaeelpourMPovažayBHermannBet al.Mapping choroidal and retinal thickness variation in type 2 diabetes using three-dimensional 1060-nm optical coherence tomography.Invest Ophthalmol Vis Sci201152(8)5311–5316
OlaMSAlhomidaASNeurodegeneration in diabetic retina and its potential drug targets.Curr Neuropharmacol201412(4)380–386
20.
BearseMAJrHanYSchneckMEAdamsAJRetinal function in normal and diabetic eyes mapped with the slow flash multifocal electroretinogram.Invest Ophthalmol Vis Sci200445(1)296–304
21.
FletcherELPhippsJAWardMMPuthusseryTWilkinson-BerkaJLNeuronal and glial cell abnormality as predictors of progression of diabetic retinopathy.Curr Pharm Des200713(26)2699–2712
22.
van DijkHWVerbraakFDStehouwerMet al.Association of visual function and ganglion cell layer thickness in patients with diabetes mellitus type 1 and no or minimal diabetic retinopathy.Vision Res201151(2)224–228
23.
JindalVNeurodegeneration as a primary change and role of neuroprotection in diabetic retinopathy.Mol Neurobiol201551(3)878–884
24.
van DijkHWVerbraakFDKokPHBet al.Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes.Invest Ophthalmol Vis Sci201051(7)3660–3665
25.
van DijkHWVerbraakFDKokPHBet al.Early neurodegeneration in the retina of type 2 diabetic patients.Invest Ophthalmol Vis Sci201253(6)2715–2719
26.
CarpinetoPTotoLAloiaRet al.Neuroretinal alterations in the early stages of diabetic retinopathy in patients with type 2 diabetes mellitus.Eye (Lond)201630(5)673–679
27.
ChhablaniJSharmaAGoudAet al.Neurodegeneration in Type 2 Diabetes: Evidence From Spectral-Domain Optical Coherence Tomography.Invest Ophthalmol Vis Sci201556(11)6333–6338
28.
NgDSChiangPPTanGet al.Retinal ganglion cell neuronal damage in diabetes and diabetic retinopathy.Clin Experiment Ophthalmol201644(4)243–250
29.
VujosevicSMidenaERetinal layers changes in human preclinical and early clinical diabetic retinopathy support early retinal neuronal and Müller cells alterations.J Diabetes Res20132013905058
30.
KalesnykasGOglesbyENZackDJet al.Retinal ganglion cell morphology after optic nerve crush and experimental glaucoma.Invest Ophthalmol Vis Sci201253(7)3847–3857
31.
SchubertMGautamDSurjoDet al.Role for neuronal insulin resistance in neurodegenerative diseases.Proc Natl Acad Sci U S A2004101(9)3100–3105
32.
OttAStolkRPvan HarskampFPolsHAHofmanABretelerMMDiabetes mellitus and the risk of dementia: The Rotterdam Study.Neurology199953(9)1937–1942
33.
SteenETerryBMRiveraEJet al.Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease—is this type 3 diabetes?J Alzheimers Dis20057(1)63–80
34.
PayneAJKajaSSabatesNRKoulenPA case for neuroprotection in ophthalmology: developments in translational research.Mo Med2013110(5)429–436
35.
van DijkHWKokPHBGarvinMet al.Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy.Invest Ophthalmol Vis Sci200950(7)3404–3409
36.
ZhangXFrancisBADastiridouAet al;Advanced Imaging for Glaucoma Study Group.Longitudinal and Cross-Sectional Analyses of Age Effects on Retinal Nerve Fiber Layer and Ganglion Cell Complex Thickness by Fourier-Domain OCT. Transl Vis Sci Technol20165(2)1
